Page 58 - LECTURE NOTES
P. 58

Urea 10% cream or ointment  as an emulsifier, aqueous cream in folds. - Treat any

               super infection with betadine or antibiotics if necessary.
               Vitamin D3 analogues:  Calcitriol and Calcipotriol, act by regulating keratinocyte

               proliferation and maturation.
               Retinoids Tazarotene, available in 0.05% and 0.1% gels, is  a topical retinoid for the

               treatment of psoriasis; can regulate keratinocyte proliferation and maturation. Main side
               effect is irritation. Special precaution: women of child-bearing age.



               PUVA photo chemotherapy -also known as PUVA, a photosensitizing drug methoxsalen
               (8-methoxypsoralens) is given orally, followed by ultraviolet A (UVA) irradiation to treat

               patients with more extensive disease. UVA irradiation utilizes light with wavelengths

               320-400 nm. PUVA, decreases cellular proliferation by interfering with DNA synthesis,
               and also induces a localized immunosuppression by its action on T lymphocytes.

               Therapy usually is given 2-3 times per week on an outpatient basis, with maintenance
               treatments every 2-4 weeks until remission. Adverse effects of PUVA therapy include

               nausea, pruritus, and burning. Long-term complications include increased risks of photo
               damage and skin cancer. PUVA has been combined with oral retinoid derivatives to

               decrease the cumulative dose of UVA radiation to the skin.


               Systemic therapy

               In severe cases, retinoids, methotrexate, cyclosporine, and hydroxyurea may be used.
               Systemic corticosteroids are generally contraindicated, and they can exacerbate a very

               severe type of psoriasis called pustular psoriasis, which has a high rate of mortality


                3.13. Exfoliative Dermatitis Erythroderma Syndrome “Skin Failure”



               The exfoliative erythroderma syndrome (EES)  is a serious, at times life-threatening
               reaction pattern of the skin characterized by generalized and uniform redness and

               scaling Involving practically the entire  skin (>90% surface) and associated with
               systemic “toxicity,” generalized lymphadenopathy, and fever. In the acute and sub

               acute phases, there is rapid onset of generalized vivid red erythema and fine branny

               scales; the patient feels hot and cold, shivers, and has fever. In the chronic EES, the

                                                             52
   53   54   55   56   57   58   59   60   61   62   63